Lavipharm S.A. (ATH:LAVI)
Greece
· Delayed Price · Currency is EUR 1.566
+0.036 (2.35%)
Apr 29, 2026, 11:03 AM EET
Lavipharm Revenue
In the year 2025, Lavipharm had annual revenue of 62.58M EUR with 18.20% growth. Lavipharm had revenue of 20.97M in the quarter ending December 31, 2025, with 55.41% growth.
Revenue
62.58M
Revenue Growth
+18.20%
P/S Ratio
4.13
Revenue / Employee
221.93K
Employees
282
Market Cap
258.64M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 62.58M | 9.64M | 18.20% |
| Dec 31, 2024 | 52.95M | 5.11M | 10.68% |
| Dec 31, 2023 | 47.84M | 8.78M | 22.48% |
| Dec 31, 2022 | 39.06M | -667.00K | -1.68% |
| Dec 31, 2021 | 39.72M | 2.09M | 5.54% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Dimand | 59.87M |
| Evropi Holdings Societe Anonyme | 11.06M |
| Intracom Holdings | 959.00K |
| Fourlis Holdings | 593.67M |
| Trade Estates REIC | 52.26M |
| Austriacard Holdings AG | 360.17M |
| Bank of Greece | 711.54M |
| Trastor Real Estate Investment Company | 42.59M |